271 related articles for article (PubMed ID: 30806335)
1. Therapeutic Potential of Melatonin in the Regulation of MiR-148a-3p and Angiogenic Factors in Breast Cancer.
Lacerda JZ; Ferreira LC; Lopes BC; Aristizábal-Pachón AF; Bajgelman MC; Borin TF; Zuccari DAPC
Microrna; 2019; 8(3):237-247. PubMed ID: 30806335
[TBL] [Abstract][Full Text] [Related]
2. Melatonin restrains angiogenic factors in triple-negative breast cancer by targeting miR-152-3p: In vivo and in vitro studies.
Marques JHM; Mota AL; Oliveira JG; Lacerda JZ; Stefani JP; Ferreira LC; Castro TB; Aristizábal-Pachón AF; Zuccari DAPC
Life Sci; 2018 Sep; 208():131-138. PubMed ID: 29990486
[TBL] [Abstract][Full Text] [Related]
3. The repressive effect of miR-148a on Wnt/β-catenin signaling involved in Glabridin-induced anti-angiogenesis in human breast cancer cells.
Mu J; Zhu D; Shen Z; Ning S; Liu Y; Chen J; Li Y; Li Z
BMC Cancer; 2017 May; 17(1):307. PubMed ID: 28464803
[TBL] [Abstract][Full Text] [Related]
4. Melatonin Differentially Modulates NF-кB Expression in Breast and Liver Cancer Cells.
Colombo J; Jardim-Perassi BV; Ferreira JPS; Braga CZ; Sonehara NM; Júnior RP; Moschetta MG; Girol AP; Zuccari DAPC
Anticancer Agents Med Chem; 2018; 18(12):1688-1694. PubMed ID: 29384062
[TBL] [Abstract][Full Text] [Related]
5. [Hsa-miR-148a-3p promotes malignant behavior of breast cancer cells by downregulating DUSP1].
Xu J; Lin L; Chen Q; Li L
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Sep; 43(9):1515-1524. PubMed ID: 37814866
[TBL] [Abstract][Full Text] [Related]
6. miR-142-3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach-1 expression.
Mansoori B; Mohammadi A; Ghasabi M; Shirjang S; Dehghan R; Montazeri V; Holmskov U; Kazemi T; Duijf P; Gjerstorff M; Baradaran B
J Cell Physiol; 2019 Jun; 234(6):9816-9825. PubMed ID: 30480817
[TBL] [Abstract][Full Text] [Related]
7. Effect of melatonin on tumor growth and angiogenesis in xenograft model of breast cancer.
Jardim-Perassi BV; Arbab AS; Ferreira LC; Borin TF; Varma NR; Iskander AS; Shankar A; Ali MM; de Campos Zuccari DA
PLoS One; 2014; 9(1):e85311. PubMed ID: 24416386
[TBL] [Abstract][Full Text] [Related]
8. LINC00339 promotes cell proliferation, migration, and invasion of ovarian cancer cells via miR-148a-3p/ROCK1 axes.
Pan L; Meng Q; Li H; Liang K; Li B
Biomed Pharmacother; 2019 Dec; 120():109423. PubMed ID: 31550677
[TBL] [Abstract][Full Text] [Related]
9. The role of melatonin on miRNAs modulation in triple-negative breast cancer cells.
Ferreira LC; Orso F; Dettori D; Lacerda JZ; Borin TF; Taverna D; Zuccari DAPC
PLoS One; 2020; 15(2):e0228062. PubMed ID: 32012171
[TBL] [Abstract][Full Text] [Related]
10. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
Shi J; Tan S; Song L; Song L; Wang Y
Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
[TBL] [Abstract][Full Text] [Related]
11. Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer.
Zhang J; Zhang Y; Shen W; Fu R; Ding Z; Zhen Y; Wan Y
Biomed Pharmacother; 2019 Sep; 117():109058. PubMed ID: 31176168
[TBL] [Abstract][Full Text] [Related]
12. microRNAs: Key regulators of chemotherapy response and metastatic potential via complex control of target pathways in esophageal adenocarcinoma.
Matuszcak C; Lindner K; Eichelmann AK; Hussey DJ; Haier J; Hummel R
Surg Oncol; 2018 Sep; 27(3):392-401. PubMed ID: 30217293
[TBL] [Abstract][Full Text] [Related]
13. MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer.
Xu X; Zhang Y; Jasper J; Lykken E; Alexander PB; Markowitz GJ; McDonnell DP; Li QJ; Wang XF
Oncotarget; 2016 Apr; 7(15):20381-94. PubMed ID: 26967387
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer.
Zheng B; Liang L; Wang C; Huang S; Cao X; Zha R; Liu L; Jia D; Tian Q; Wu J; Ye Y; Wang Q; Long Z; Zhou Y; Du C; He X; Shi Y
Clin Cancer Res; 2011 Dec; 17(24):7574-83. PubMed ID: 21994419
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene.
Yang J; Zhang Z; Chen C; Liu Y; Si Q; Chuang TH; Li N; Gomez-Cabrero A; Reisfeld RA; Xiang R; Luo Y
Oncogene; 2014 Jun; 33(23):3014-23. PubMed ID: 23831570
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of hyperglycemia-induced angiogenesis and breast cancer tumor growth by systemic injection of microRNA-467 antagonist.
Krukovets I; Legerski M; Sul P; Stenina-Adognravi O
FASEB J; 2015 Sep; 29(9):3726-36. PubMed ID: 26018675
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-542-3p inhibits tumour angiogenesis by targeting angiopoietin-2.
He T; Qi F; Jia L; Wang S; Song N; Guo L; Fu Y; Luo Y
J Pathol; 2014 Apr; 232(5):499-508. PubMed ID: 24403060
[TBL] [Abstract][Full Text] [Related]
18. Tumor cell-secreted angiogenin induces angiogenic activity of endothelial cells by suppressing miR-542-3p.
He T; Qi F; Jia L; Wang S; Wang C; Song N; Fu Y; Li L; Luo Y
Cancer Lett; 2015 Nov; 368(1):115-125. PubMed ID: 26272182
[TBL] [Abstract][Full Text] [Related]
19. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
Wu H; Li J; Guo E; Luo S; Wang G
Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
[TBL] [Abstract][Full Text] [Related]
20. Glutamate metabotropic receptor 4 (GRM4) inhibits cell proliferation, migration and invasion in breast cancer and is regulated by miR-328-3p and miR-370-3p.
Xiao B; Chen D; Zhou Q; Hang J; Zhang W; Kuang Z; Sun Z; Li L
BMC Cancer; 2019 Sep; 19(1):891. PubMed ID: 31492116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
